28PImpact of the 21-gene assay on treatment decisions in high-risk patients with ER-positive HER2-negative early breast cancer: Results of the KARMA Dx study
Llombart, A, Andrés, R, Anton Torres, A, Martinez, N, Rodriguez, C, Sánchez-Rovira, P, Rojas, B, Ruiz Borrego, M, Bermejo, B, Martinez de Dueñas, EVolume:
30
Journal:
Annals of Oncology
DOI:
10.1093/annonc/mdz095.027
Date:
May, 2019
Fichier:
PDF, 86 KB
2019
File converter
Plus de résultats de recherche
More benefits 
